scispace - formally typeset
F

Fariborz Ghaffarpasand

Researcher at Shiraz University of Medical Sciences

Publications -  137
Citations -  1940

Fariborz Ghaffarpasand is an academic researcher from Shiraz University of Medical Sciences. The author has contributed to research in topics: Population & Glasgow Outcome Scale. The author has an hindex of 22, co-authored 129 publications receiving 1600 citations. Previous affiliations of Fariborz Ghaffarpasand include Jahrom University & Isfahan University of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Non alcoholic fatty liver disease in southern Iran: a population based study.

TL;DR: NAFLD in Iranian population is associated with male gender, old age, obesity, and features of metabolic syndrome, and patients with NAFLD had significantly higher prevalence of metabolic Syndrome when compared to healthy subjects.
Journal ArticleDOI

Evaluation of sperm’s chromatin quality with acridine orange test, chromomycin A3 and aniline blue staining in couples with unexplained recurrent abortion

TL;DR: Evaluation of the sperm’s quality via CMA3 and AB staining could be considered as one of the complementary tests of semen analysis for assessment of male factor in couples with spontaneous recurrent abortion.
Journal ArticleDOI

The value of hysteroscopy in diagnosis of chronic endometritis in patients with unexplained recurrent spontaneous abortion

TL;DR: Hysteroscopy, with high sensitivity and acceptable specificity, is suitable for the diagnosis of CE in those with unexplained RSA and CE should be taken into consideration inThose with secondary unexplained RSA.
Journal ArticleDOI

Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study.

TL;DR: It is demonstrated that the combination of metformin and simvastatin could lead to a better reduction of T and LH levels and thus reversing the LH:FSH ratio, lipid profile, and insulin resistance in patients withPCOS and may be an appropriate management option for patients with PCOS.